ctrl K

Price Alert

Unicycive Therapeutics In... (UNCY)

NASDAQ: UNCY · Real-Time Price · USD

4.06

-0.02 (-0.49%)

At close: Aug 19, 2025, 11:46 AM

Unicycive Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	26.14M	9.7M	455K	16.58M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-174K	-333K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	939K	325K	159K	126K
Total Current Assets	30.95M	13.4M	2.64M	18.41M
Property-Plant & Equipment	720K	792K	174K	333K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	720K	792K	174K	333K
Total Assets	31.67M	14.19M	2.82M	18.74M
Account Payables	966K	821K	846K	713K
Deferred Revenue	n/a	-18K	n/a	n/a
Short-Term Debt	564K	18K	155K	151K
Other Current Liabilities	18.94M	13.12M	-109K	-122K
Total Current Liabilities	24.12M	17.53M	3.28M	2.1M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	117K	466K	1.05K	155K
Total Liabilities	24.24M	18M	3.28M	2.26M
Total Debt	773K	811K	155K	306K
Common Stock	114K	35K	15K	15K
Retained Earnings	-101.27M	-64.54M	-34M	-15.94M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	7.43M	-3.81M	-466K	16.48M
Total Investments	n/a	n/a	n/a	n/a